Atipamezole hydroChloride - CAS 104075-48-1
Catalog number: 104075-48-1
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H16N2.HCl
Molecular Weight:
248.75
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>99 %
Appearance:
White Solid
Synonyms:
1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-, monohydrochloride;Atipamezole HCL;4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole hydrochloride;4-(2-Ethyl-2-indanyl)imidazole hydrochloride;Atipamezole hydrochloride;Unii-2W4279571x
Solubility:
DMSO > 47mg/ml
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
367.1ºC at 760mmHg
Melting Point:
216-219°C
Density:
1.115g/cm3
InChIKey:
PCCVCJAQMHDWJY-UHFFFAOYSA-N
InChI:
1S/C14H16N2.ClH/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14;/h3-6,9-10H,2,7-8H2,1H3,(H,15,16);1H
Canonical SMILES:
CCC1(C2=CN=CN2)CC3=CC=CC=C3C1.Cl
1.Anesthetic and cardiopulmonary effects of intramuscular morphine, medetomidine, ketamine injection in dogs.
Ueyama Y1, Waselau AC, Wiese AJ, Muir WW. Vet Anaesth Analg. 2008 Nov;35(6):480-7. doi: 10.1111/j.1467-2995.2008.00415.x. Epub 2008 Aug 15.
OBJECTIVE: To determine the quality and duration of anesthesia and the cardiopulmonary effects of a morphine, medetomidine, ketamine (MMK) combination administered intramuscularly (IM) to dogs.
2.Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
Finnema SJ1, Hughes ZA2, Haaparanta-Solin M2, Stepanov V2, Nakao R2, Varnäs K2, Varrone A2, Arponen E2, Marjamäki P2, Pohjanoksa K2, Vuorilehto L2, Babalola PA2, Solin O2, Grimwood S2, Sallinen J2, Farde L2, Scheinin M2, Halldin C2. Int J Neuropsychopharmacol. 2014 Dec 13;18(3). pii: pyu081. doi: 10.1093/ijnp/pyu081.
BACKGROUND: The neurotransmitter norepinephrine has been implicated in psychiatric and neurodegenerative disorders. Examination of synaptic norepinephrine concentrations in the living brain may be possible with positron emission tomography (PET), but has been hampered by the lack of suitable radioligands.
3.Effects of alpha-adrenergic agonists on pain modulation in diffuse noxious inhibitory control.
Sanada T1, Kohase H, Makino K, Umino M. J Med Dent Sci. 2009 Mar;56(1):17-24.
BACKGROUND: Diffuse noxious inhibitory control (DNIC) is thought to be mediated by neural networks in supraspinal brain structures. The descending antinociceptive system (DAS) is an important component of the DNIC neural network, but the precise structure of the neural network and the related neurotransmitters have not been examined.
4.Effects of a medetomidine-ketamine combination on Schirmer tear test I results of clinically normal cats.
Di Pietro S, Macrì F, Bonarrigo T, Giudice E, Palumbo Piccionello A, Pugliese A. Am J Vet Res. 2016 Mar;77(3):310-4. doi: 10.2460/ajvr.77.3.310.
OBJECTIVE To evaluate the effects of a medetomidine-ketamine combination on tear production of clinically normal cats by use of the Schirmer tear test (STT) 1 before and during anesthesia and after reversal of medetomidine with atipamezole. ANIMALS 40 client-owned crossbred domestic shorthair cats (23 males and 17 females; age range, 6 to 24 months). PROCEDURES A complete physical examination, CBC, and ophthalmic examination were performed on each cat. Cats with no abnormalities on physical and ophthalmic examinations were included in the study. Cats were allocated into 2 groups: a control group (n = 10 cats) anesthetized by administration of a combination of medetomidine hydrochloride (80 μg/kg) and ketamine hydrochloride (5 mg/kg), and an experimental group (30) anesthetized with the medetomidine-ketamine combination and reversal by administration of atipamezole. Tear production of both eyes of each cat was measured by use of the STT I before anesthesia, 15 minutes after the beginning of anesthesia, and 15 minutes after administration of atipamezole.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 681806-46-2 BRL 44408 maleate

BRL 44408 maleate
(CAS: 681806-46-2)

BRL 44408 maleate is a selective α2A-adrenoceptor antagonist (Ki = 1.7 nM and 144.5 nM at α2A and α2B-adrenergic receptors, respectively). BRL 44408 increases h...

CAS 90274-24-1 Ractopamine hydrochloride

Ractopamine hydrochloride
(CAS: 90274-24-1)

Ractopamine hydrochloride, a phenethanolamine with beta-adrenergic agonist properties, has the effects of increasing muscle mass and decreasing body fat in rode...

CAS 157066-77-8 SNAP 5089

SNAP 5089
(CAS: 157066-77-8)

SNAP 5089 is an α1A-adrenoceptor antagonist with > 600-fold selectivity over other adrenoceptors (Ki = 0.35, 220, 370, 540, 800 and 1200 nM for α1A, α1B, α2C, α...

CAS 148274-76-4 MG 1

MG 1
(CAS: 148274-76-4)

An α1 adrenergic receptor antagonist

CAS 40616-75-9 DSP-4

DSP-4
(CAS: 40616-75-9)

DSP-4 has been found to be an adrenergic neurotoxin and could exhibit neurotoxic effects on both peripheral and central noradrenergic neurons.

CAS 4205-91-8 Clonidine Hydrochloride

Clonidine Hydrochloride
(CAS: 4205-91-8)

Clonidine HCl is a direct-acting α2 adrenergic agonist with an ED50 of 0.02±0.01 mg/kg.

CAS 53671-71-9 ICI 89406

ICI 89406
(CAS: 53671-71-9)

ICI 89406 is a selective β-adrenergic antagonist. It is a low efficacy partial agonist and does not affect resting cardiac parameters.

CAS 804518-03-4 Milveterol hydrochloride

Milveterol hydrochloride
(CAS: 804518-03-4)

Milveterol is a long-acting β(2)-adrenoceptor agonist under the development of GlaxoSmithKline. Phase II trials for the treatment of Chronic obstructive pulmona...

CAS 81161-17-3 Esmolol HCl

Esmolol HCl
(CAS: 81161-17-3)

Esmolol is a cardioselective beta1 receptor blocker with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane ...

CP 59430
(CAS: 86329-06-8)

CP 59430 is an azide analog of prazosin. It is a selective alpha 1-adrenergic receptor antagonist.

Aptazapine maleate
(CAS: 71576-41-5)

Aptazapine is a tetracyclic antidepressant. It was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. Aptazapine is...

CAS 1491-59-4 Oxymetazoline

Oxymetazoline
(CAS: 1491-59-4)

Oxymetazoline, an imidazol derivative, has been found to be an adrenergic receptor agonist that could be an effective topical decongestant.

CAS 93379-54-5 (S)-(-)-Atenolol

(S)-(-)-Atenolol
(CAS: 93379-54-5)

(S)-(-)-Atenolol is the active enantiomer of (RS)-atenolol, which is a cardioselective β-adrenergic blocker. It has antihypertensive, antianginal, antiarrhythmi...

CAS 151126-84-0 CL 316243 disodium salt

CL 316243 disodium salt
(CAS: 151126-84-0)

The sodium salt form of CL 316243, which has been found to be a β3-adrenoceptor agonist and could probably decrease blood insulin as well as glucose levels.

CAS 70024-40-7 Terazosin HCl

Terazosin HCl
(CAS: 70024-40-7)

Terazosin is a selective alpha 1 antagonist used for treatment of symptoms of an enlarged prostate (BPH).

CAS 57775-29-8 Carazolol

Carazolol
(CAS: 57775-29-8)

Carazolol is a β-adrenergic receptor antagonist.

CAS 106463-17-6 Tamsulosin HCl

Tamsulosin HCl
(CAS: 106463-17-6)

The hydrochloride salt form of Tamsulosin which could block on the sympathetic α1 receptor, especially selectively bind to the α1A receptor so that has been fou...

CAS 63659-19-8 Betaxolol HCl

Betaxolol HCl
(CAS: 63659-19-8)

Betaxolol is a β1 adrenergic receptor blocker with IC50 of 6 μM.

CP-114271
(CAS: 162326-86-5)

CP-114271, a thiazole derivative, has been found to be a β3 adrenergic receptor agonist that was once studied in obesity therapy.

CAS 33402-03-8 Metaraminol tartrate

Metaraminol tartrate
(CAS: 33402-03-8)

Metaraminol is a stereoisomer of meta-hydroxynorephedrine, acts as An adrenergic agonist that increases both systolic and diastolic blood pressure.

Chemical Structure

CAS 104075-48-1 Atipamezole hydroChloride

Quick Inquiry

Verification code

Featured Items